Matthew Stark

Matthew Stark has a strong background in clinical and regulatory affairs. Matthew is currently working as the Vice President of Clinical and Regulatory Affairs at Axon Therapies Inc. Prior to this, they held the position of Vice President of Clinical Programs and Regulatory Affairs at Cardiac Dimensions from 2018 to 2022. Before that, Matthew was the Vice President of Regulatory and Clinical Affairs at Bolton Medical, a Werfenlife Company, from 2016 to 2018. Matthew also served as the Director of Medical Affairs at Spectranetics from 2014 to 2016 and as a Medical Liaison at Spectranetics, Inc. from 2012 to 2014. Matthew began their career with Spectranetics in 2009, where they held the position of Senior Clinical Affairs Manager, managing and designing clinical trials. Prior to that, they worked as a Clinical Study Manager at W.L. Gore & Associates, INC from 2006 to 2009. Matthew also has experience as a Licensing Associate at UVA Patent Foundation from 2004 to 2006 and as an Extern in the UVA Biotechnology Training Grant Program at Amgen, INC in 2005.

Matthew Stark completed their education with a Master of Business Administration degree in Finance, Economics, and Entrepreneurship from The University of Chicago Booth School of Business. Prior to that, they pursued a Doctorate of Philosophy in Molecular Physiology from the University of Virginia. Matthew's undergraduate studies were focused on Biochemistry, as they obtained a Bachelor of Arts degree from the University of Colorado Boulder. The information does not provide details about any education at the University of Missouri-Columbia.